Clear, evidence-based guidelines needed for NAFLD in type 2 diabetes

New findings published in Diabetic Medicine highlighted the urgent need for clear, evidence-based guidelines for managing nonalcoholic fatty liver disease in individuals with type 2 diabetes.“In addition to providing evidence-based pathways, implementing an assessment of liver fibrosis into primary health care requires clinicians to carry out this guidance,” Elizabeth E. Powell, MBBS, PhD, Centre for Liver Disease Research in the Translational Research Institute at the University of Queensland and the department of gastroenterology and hepatology at Princess Alexandra Hospital inRead More

Categories: News

Related Articles

HHS Notice of Benefit and Payment Parameters for 2026 Proposed Rule

On October 10, 2024, the Centers for Medicare & Medicaid Services (CMS), in collaboration with the U.S. Department of Health and Human Services (HHS), published…

Jane Smith November 11, 2024

Nonalcoholic fatty liver disease linked to increased risk for dementia

Patients with nonalcoholic fatty liver disease had an increased risk for dementia, with stronger risk existing for those with comorbid heart disease or stroke, according…

Non-liver-related mortality can be higher in NAFLD ‘depending on age, fibrosis stage’

A patient outcomes simulator found that non-liver-related mortality could surpass liver-related mortality in patients with nonalcoholic fatty liver disease, depending on age and fibrosis stage…

October 5, 2022

Type 2 diabetes incidence ’30 times greater’ for children with NAFLD vs. high-risk groups

Researchers reported an increased risk for type 2 diabetes in children with nonalcoholic fatty liver disease, highlighting the need for targeted prevention and screening, according…

Sex hormone-binding globulin level may predict liver fibrosis for men with NAFLD

SAN DIEGO — Higher sex hormone-binding globulin levels may predict liver fibrosis for men with nonalcoholic fatty liver disease, according to a presenter at the…